Personalized vs. Precision? Let ’ s Call It Medicine

NCI's Center for Cancer Research (CCR) Grand Rounds Dr. Howard McLeod is Medical Director of the DeBartolo Family Personalized Medicine Institute at the Moffitt Cancer Center. He is Chair of the Department of Individualized Cancer Management and a State of Florida Endowed Chair in Cancer Research. He is also a senior member of the Division of Population Sciences and Professor at the University of South Florida. Dr. McLeod is Chair of the NHGRI eMERGE network external scientific panel and a recent member of the FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology and the NIH Human Genome Advisory Council. Since 2002, Dr. McLeod has been Vice Chair for Pharmacogenomics for the NCI-supported Alliance for Clinical Trials in Oncology group, overseeing the largest oncology pharmacogenomics portfolio in the world. Dr. McLeod is also a 1000 Talent Scholar of China and a Professor at Central South University in Changsha, China. He has published over 500 peer reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to advance individualized medicine.Air date: 12/8/2017 12:00:00 PM
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video